The term late-breaking is often used to describe news events that occur after the official publication deadline. It may also refer to a newspaper article that contains information or results that was not available when the paper went to press. In the case of a scientific meeting, the term late-breaking describes research that has been published after the official abstract submission deadline but is still relevant to the congress program.
Submissions in this category will be screened through the same process as the general abstracts. Accepted abstracts will be grouped in one of two groups (Late Breaking Clinical Trials: Immunologic and Late Breaking Clinical Trials: Non-Immunologic) for oral presentation at SLEEP 2025. Presenters of accepted late-breaking abstracts will be notified via email by September 24.
Abstracts must contain new, original data that was not available prior to the MSMilan2023 General Abstract Submission Deadline earlier this year. Late-breaking submissions cannot be duplicates of abstracts submitted and reviewed during the general submission process or of other recent national meetings. In addition, late-breaking abstracts cannot include data that was presented at a previous MSMilan meeting or already published in an online or PubMed indexed venue by the time of submission.
All abstracts must be written in clear, concise and grammatically correct English. Authors are encouraged to proofread their abstract before submitting it for consideration. A maximum of two late-breaking abstracts can be submitted by an individual registrant. The first author on each abstract must be an ASTS or AST-member. Conflict-of-interest disclosure statements must be submitted for each presenting author. Authors will be required to provide a short biography and image for the website and congress app.